Definitive Contract 75D30120C09486

This is a $459,721 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Yale University, a private research university, to conduct research on "Microbiome Disruption Indices." The contract has no set-aside designation. As a subcontractor, the University of Maryland, Baltimore (UMB) is providing frozen patient samples and clinical data to support the research effort. This contract award is part of Yale University's broader portfolio of federal prime...

This is a $414,315 firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to Yale University, a private research university, to assess the contamination and survivability of SARS-CoV-2 on surfaces. The contract, which has a period of performance through September 27, 2022, was awarded on September 28, 2020 and is designated as related to the Coronavirus COVID-19 national interest action. No set-aside was used for this award. Yale University is registered in the...

This is a definitive, firm fixed price contract awarded to Yale University by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract, valued at $1,980,573.00, is for the FY22 Broad Agency Announcement (BAA) YALE, with a period of performance through March 18, 2025. The contract is not set-aside. As a private university, Yale University is registered in the System for Award Management (SAM) and provides a range of services including education and research. Through this...

This is a $847,345.00 firm fixed price federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Yale University, a private non-profit research university, to conduct research on virus genomics and human mobility patterns related to the spread of SARS-CoV-2. The contract has a completion date of September 20, 2022 and was originally awarded on September 22, 2020. As part of this contract, Yale University has issued a subcontract to...

This is a Firm Fixed Price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Yale University to conduct SARS-CoV-2 sero-surveillance in indigenous casino workers. The contract has a ceiling value of $699,595.00 and a period of performance through April 30, 2022. There was no set-aside used for this award. As a private research university, Yale University has a history of providing research, analysis, and testing services to various federal agencies through...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $252,340.80 firm fixed price contract to Yale University, a private non-profit university, for Health Equity Consulting Support related to the COVID-19 pandemic. The contract was awarded on May 14, 2021 with a period of performance through May 13, 2022. No set-aside was used for this contract. As a leading research institution, Yale University has experience providing expertise...

This firm-fixed-price federal contract, valued at $393,011.00, was awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of the University of Pennsylvania (Penn) to conduct a respiratory microbiome study. The contract does not have a set-aside designation. Penn, a renowned private research university and academic medical center, has a long history of performing advanced biomedical research and providing healthcare services to the federal government through contracts and...

This is a $4,916,756.12 firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Utah Office of Sponsored Projects. The contract is for "2021 DOMAIN 1-A015 MODELING AND NOVEL DATA" work under the CDC's Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) multi-award indefinite delivery/indefinite quantity (IDIQ) contract. The contract has an ultimate completion date of August 31,...

The federal contract award 75D30121C10084 was issued by the Centers for Disease Control and Prevention (CDC) to Emory University for "SARS - COV-2 APPLIED RESEARCH FOR NCEZID". The $622,108.90 firm-fixed price contract runs through November 28, 2022 and does not have a set-aside designation. Emory University, a private research university based in Atlanta, Georgia, has an extensive track record of performing federally funded research and providing services to the government. This...

This is a $304,683 firm fixed-price federal contract awarded by the Centers for Disease Control and Prevention (CDC) to the Regents of the University of Michigan for a project titled "MICROBIOME ASSESSMENT". The award date was September 19, 2016, and the ultimate completion date is March 31, 2018. The contract does not have a set-aside designation. The Regents of the University of Michigan is the prime contractor, and there are no major subcontractors identified. The University of...